ta-cd
Vaccineexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2003 (NCT00965263)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- cocaineImmunity, active
cocaine immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ta-cd
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00969878 | Phase 2 | Aug 1, 2010 | Baylor University, Celtic Pharma Development Services, Columbia University, Department of Veteran Affairs, Johns Hopkins University, National Institute on Drug Abuse (NIDA), University of Cincinnati, University of Pennsylvania |
| NCT00965263 | Phase 2 | Mar 1, 2003 | Columbia University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Columbia University | Academic/Hospital | 2 | 1 | 1 | 2003 |
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Celtic Pharma Development Services | For profit | 1 | 0 | 1 | 2010 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2010 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2010 |
| University of Cincinnati | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2010 |
8 organizations
Page 1 / 1